Back to SCHRODER INVESTMENT MANAGEMENT GROUP SCHRODER INVESTMENT MANAGEMENT GROUP

PTGXPTGX

Showing 0 of 2 quarters

Position history for SCHRODER INVESTMENT MANAGEMENT GROUPSCHRODER INVESTMENT MANAGEMENT GROUP's holdings in Protagonist Therapeutics, Inc.

No. Schroder Investment Management Group exited its PTGX position in Q1 2024. Its Q4 2023 13F listed 19,900 shares worth $456,307. Schroder Investment Management Group first reported PTGX in Q4 2023 and held it in 1 quarterly 13F filing.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used